Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review. (Q38035199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

11 February 2020

main subject

feces

0 references

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Ioannis D Kostakis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Kyriaki G Cholidou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Aristeidis G Vaiopoulos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Despina Perrea

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

George Vaos

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

17 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

11 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

309-319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22899243%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Special issues in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Diagnosis and management of inflammatory bowel disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Challenges and progress in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Inflammatory bowel diseases in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Inflammatory bowel disease in children: current trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Inflammatory bowel diseases: the paediatric gastroenterologist's perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Inflammatory bowel disease in children: an overview for pediatric healthcare providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Role of capsule endoscopy in inflammatory bowel disease: where we are and where we are going

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Pediatric inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Diagnostic Problems and Advances in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Laboratory evaluation of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn's disease: preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Leukocytapheresis in pediatric patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

The role of calprotectin in obstetrics and gynecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

S100A8 and S100A9 in human arterial wall. Implications for atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Inflammation: a novel mechanism for the transport of extracellular nucleotide-induced arachidonic acid by S100A8/A9 for transcellular metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Fecal HMGB1 Is a Novel Marker of Intestinal Mucosal Inflammation in Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2347-5

Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up

21 January 2018

1 reference

12 December 2020

Faecal calprotectin in children with chronic gastrointestinal symptoms

1 reference

12 December 2020

Fecal calprotectin in healthy term and preterm infants

1 reference

12 December 2020

Inflammatory bowel disease

1 reference

12 December 2020

Fecal calprotectin as a promising marker of inflammatory diseases

1 reference

12 December 2020

No Relation Between Disease Activity Measured by Multiple Methods and REE in Childhood Crohn Disease

1 reference

12 December 2020

Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease

1 reference

12 December 2020

Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration

1 reference

12 December 2020

Calprotectin - a pleiotropic molecule in acute and chronic inflammation.

1 reference

12 December 2020

Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease

1 reference

12 December 2020

Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease

1 reference

12 December 2020

Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children

1 reference

12 December 2020

Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases

1 reference

12 December 2020

Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease

1 reference

12 December 2020

Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay

1 reference

12 December 2020

Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease

1 reference

12 December 2020

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

1 reference

12 December 2020

Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms

1 reference

12 December 2020

Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease

1 reference

12 December 2020

Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response

1 reference

12 December 2020

[Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease]

1 reference

12 December 2020

A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn's disease

1 reference

12 December 2020

The diagnosis and treatment of Crohn's disease and ulcerative colitis

1 reference

12 December 2020

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children

1 reference

12 December 2020

Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease

1 reference

12 December 2020